Mayer EL, Ren Y, Wagle N, Mahtani R, et al. PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Bre J Clin Oncol 2024 Mar 21:JCO2301940. doi: 10.1200/JCO.23.01940.
PMID: 38513188